Work

Alliance A091103: A multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.10568

Authors: Sandra P. D'Angelo, Michelle R. Mahoney, Brian Andrew Van Tine, Douglas Adkins, Maria T. Grosse Perdekamp, Mercedes M. Condy, Eliza Woodward Hartley, Cristina R. Antonescu, Gary K. Schwartz, William D. Tap

Institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic, Washington University in St. Louis, Cancer Care Specialists of Illinois, Columbia University Irving Medical Center

Language: English

Topic: Vascular Tumors and Angiosarcomas

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4254524519

Cites:

Cited by:

Related to: 10